Home
Shares
F&O
Mutual Funds
IPO
Commodity
Portfolio
Financial Planning
Insurance
Loans
News Centre
About Us
Markets
Companies
Research
Industries
E-Mail Page
Get NAV
Snapshot
Portfolio
Dividends
News
Interviews
Charts
Get Quote
Snapshot
Charts
Financials
Research
News
Wealth Tracker
Newsletter
Tax Corner
NRI Centre
Forums
E-Mail
Chat Masala
Feedback
my
Last 5 Scrips
Company
BSE Price(Rs)
% Chg
I T C Lt
334.70
0.62
Bhel
201.35
4.00
Tata Mot
303.35
0.05
Hindalco
110.15
0.90
Tata Stl
311.95
10.83
Clear All
Clear Last
Equity
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
News Watch
Sector Watch
Economy Watch
News-Natco Pharma Limited
Natco Pharma Limited
Sector:Pharmaceuticals
Pharmaceuticals - Formulations
BSE:
524816
NSE:
NATCOPHARM
Bloomberg:
NTCPH@IN
Reuters:
NATP.BO
Market Lot: 1
Face Value: 10
ISIN Demat: INE987B01018
Quotes
Snapshot
Charts
Financials
Research
Recent News
Peer Group
AGM/AM
MF Holding
Discussion Forum
BSE/NSE Notices
BSE/NSE Deals
Corporate News
05-Mar-2013
Natco Pharma surges after winning cancer drug case
IRIS
19-Dec-2012
Natco Pharma surges 5.3% on USFDA nod to launch Lansoprazole
IRIS
19-Dec-2012
Natco receives USFDA nod, to launch Lansoprazole
IRIS
04-Dec-2012
Natco valuations attractive; Buy for target of Rs 550: HEM Sec
IRIS Exclusive
29-Nov-2012
Natco surges 5% after IPAB rejects AstraZeneca appeal
IRIS
25-Jun-2012
Natco Pharma plunges 4% on Copaxone patent case
IRIS
25-Jun-2012
Natco Pharma loses Copaxone patent litigation against Teva
IRIS
25-Jun-2012
Natco loses Copaxone patent litigation against Teva; no impact on valuation
IRIS
01-Jun-2012
`Hold` Natco Pharma; target Rs 378: ICICI Direct
IRIS Exclusive
23-Mar-2012
`Hold` Natco Pharma; target price 352: ICICIdirect
IRIS Exclusive
12-Mar-2012
NATCO gets compulsory license for Naxaver
IRIS
08-Dec-2011
Natco Pharma raises Rs 675 mn via QIP
IRIS
07-Dec-2011
Natco Pharma climbs 8% after Dilip Shanghvi buys shares
IRIS
10-Nov-2011
Natco Pharma cons profit rises 8% in September qtr.
IRIS
18-Oct-2011
Natco Pharma jumps 9% on tie-up with Mabxience
IRIS
18-Oct-2011
Natco to enter bio-generics, signs up with Mabxience
IRIS
23-Jun-2011
Natco gains on tie-up with Lupin
IRIS
28-Mar-2011
Natco Pharma gets `Orphan Drug Designation` from USFDA
IRIS
15-Feb-2011
Natco Pharma earnings up 2.56% for Dec`10 qtr
IRIS
09-Feb-2011
Natco ties up with Alvogen to market Oseltamivir in US
IRIS
Home
|
Shares
|
F&O
|
Mutual Funds
|
Loans
|
Insurance
|
News Centre
Trade On-line
|
Wealth Tracker
|
Newsletters
|
Tax Corner
|
NRI Centre
|
Forums
|
E-mail
|
Chat
|
Search in myiris
|
Advertise
© All rights reserved. IRIS Business Services Limited
Disclaimer
Recent News
